✦ LIBER ✦

O3 Efficacy of second and third-line chemotherapy in patients with advanced transitional-cell carcinoma: Results of a national multicentre pooled analysis

✍ Scribed by Marongiu, M.; Atzori, F.; Santoni, M.; Derosa, L.; Di Lorenzo, G.; Masini, C.; Iacovelli, R.; Massari, F.; Raggi, D.; Burattini, L.; Biasco, E.; Federico, P.; Sabbatini, R.; Notari, F.; Ionta, M.T.; Necchi, A.

Book ID: 122201348
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 63 KB
Volume: 12
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(13)62321-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated liposomal doxorubicin as third

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

✍ Antonio Rozzi, Daniele Santini, Margherita Salerno, Francesca Bordin, Andrea Man 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 255 KB

7144 POSTER Weekly Paclitaxel as Third-l

7144 POSTER Weekly Paclitaxel as Third-line Chemotherapy in Patients With Metastatic Transitional Cell Carcinoma of Urothelial Tract: Results of a Phase II Study

✍ Rozzi, A.; Nardoni, C.; Corona, M.; Falbo, T.; De Marco, F.; Grillenzoni, L.; La 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Weekly regimen of epirubicin and paclita

Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

✍ Antonio Rozzi; Margherita Salerno; Francesca Bordin; Ferdinando De Marco; Stefan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 316 KB

Efficacy and safety of erlotinib versus

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study

✍ Tudor Ciuleanu; Lilia Stelmakh; Saulius Cicenas; Skaidrius Miliauskas; Alexandru 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 381 KB

Methotrexate-paclitaxel-epirubicin-carbo

Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study

✍ Amal Halim; Niveen Abotouk 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Pemetrexed Versus Pemetrexed and Carbopl

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

✍ Ardizzoni, A.; Tiseo, M.; Boni, L.; Vincent, A. D.; Passalacqua, R.; Buti, S.; A 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 200 KB